Custom Search
Showing posts with label Health Care Stocks. Show all posts
Showing posts with label Health Care Stocks. Show all posts

Monday, December 21, 2009

Dylan Ratigan Apologizes To Debbie Wasserman...He Was Still Correct!


























Visit msnbc.com for breaking news, world news, and news about the economy




Visit msnbc.com for breaking news, world news, and news about the economy







Dylan Ratigan Apologizes For "Very Rude" Debbie Wasserman Schultz Interview


MSNBC host Dylan Ratigan apologized Monday for his "very rude" conduct last week during an interview on health care with a Florida congresswoman.

Democrat Debbie Wasserman Schultz was explaining Friday on Ratigan's show "Morning Meeting" why she supported health care reform. Ratigan, who said he has "incredible frustration" with the way the bill treated insurance companies, asked her to explain why stocks for insurers were going up.

Schultz said she wasn't a stockbroker, and the answer apparently left Ratigan unsatisfied. He said he would "give her a brief education."

"You could be your own guest," she told him as she tried to get a word in edgewise.

Ratigan eventually waved her off, saying he didn't want her to "come on and do talking points."

On Monday, Ratigan quoted an e-mail from a viewer who said he was "very rude." He agreed with the sentiment and apologized to the congresswoman and viewers.

"Our mission and my mission on this show is to shine the light on what is really happening, whether it's health care, the banks, or a war in the Mideast," he said. "And the way I went about that on Friday was a disservice to our viewers because it got in the way of doing just that."

A message seeking comment was left Monday with Schultz's spokesman.

Ratigan is the former host of CNBC "Fast Money.".

He learned last week that his daily two-hour show, "Morning Meeting," was being cut in half and moved to the afternoon.




View Larger Map


Sources: MSNBC, Morning Meeting, Huffington Post, Google Maps

Health Care Stocks Are Hot Again, Lobbyists Win!
































Visit msnbc.com for breaking news, world news, and news about the economy








Health Care Insurance Company Stocks "On Fire!" – They’re Winning, We’re Losing




If you need a guide to the health reform debate in Washington, take a look at health insurance company stocks.

When the debate is going the right way – towards quality, affordable health care for everyone, towards getting people out from under the insurance industry’s crushing monopoly – insurance company stocks take a dive. When the debate is moving against what America wants – towards more private industry, less insurance regulations, and the like – health care stocks soar.

Right now, they’re soaring. The Indianapolis Star goes into more detail:

Shares of the Indianapolis-based health insurance giant surged to a 52-week high Thursday as the prospects for a new government-run "public option" health plan faded amid intense Senate debate. WellPoint rivals Cigna and UnitedHealth Group also hit 52-week highs.

It’s a sign, more than one observer suggested, of victory for private health insurers, which strenuously fought the Public Option.

"Obviously, the market thinks WellPoint’s a winner," said Daniel Evans, chief executive of Clarian Health, an Indianapolis-based hospital system. "If the public option is no longer on the table, then WellPoint is a winner because it’s not threatened by a government competitor."


Wall Street is what has turned our nation’s health care companies into profiteers.

16 years ago, before most of the insurance companies were publicly traded, they spent 95% of premium dollars on health care. That level is comparable to Medicare, which spends 97% of premium dollars on care. But once these companies went public and started trading on Wall Street, the relentless drive for profit drove down that percentage to where it sits today, at 81%.

Wall Street pressures directly caused insurance companies to deny more care. Wall Street accelerated the process by which insurance companies deny as much care as they can, which forces more people into bankruptcy (when they have to pay out of pocket for care their insurance company won’t cover) and leaves millions uninsured (if you’re bankrupt, it’s hard to pay premiums). And being uninsured can be a death sentence.

The way Wall Street responds to the health care debate drives these companies. When insurance company stock prices catch fire as the public health insurance option is killed in the Senate, you can bet that these companies are watching and feel supported in their effort to kill any and all health reform that would hurt their bottom line.

Wall Street-run health care is the driving reason that if the insurance companies win, we lose.

Wall Street run health care is making huge profits right now. It’s also making Americans sicker and sicker. A health care reform bill that does not take away Wall Street’s power – one without a public option, one that doesn’t mandate insurers spend 90% of their premiums on care, one without strict regulations on denying care or charging more to certain customers – will tacitly support the way the health care business works now, with Wall Street in charge.

The Senate bill, in too many ways, is the Wall Street bill. The House bill stands up to Wall Street. That’s presents real problems for the American people, problems that must be fixed before this bill is sent to the President’s desk.




View Larger Map


Sources: Firedoglake, The Indianapolis Star, MSNBC, Morning Joe Show, AP, Google Maps

Sunday, December 20, 2009

Lobbyists Cash In Big On Senate Health Care Bill



























































How Health Care Industry Lobbyists Influenced Reform Bill


David Nexon had a big problem. An early version of national health care legislation contained a $40 billion tax aimed squarely at members of the medical device trade association he represents.

Nexon, a former adviser to the late Massachusetts Sen. Ted Kennedy, went to work. He marshaled 14 people like himself -- lobbyists who were once congressional aides, many of them from staffs of congressional leaders or committees that had a hand in crafting the health care overhaul.

When Senate Democrats unveiled their bill in mid-November, Nexon's handiwork was evident. The tax on device-makers was still large -- $20 billion -- but only half what it might have been without the efforts of Nexon and his fellow lobbyists.

Nexon's team is an illustration of how deeply the health care industry has embedded itself on Capitol Hill, using former aides of lawmakers and ex-lawmakers themselves.

An analysis of public documents by Northwestern University's Medill News Service in partnership with the Tribune Newspapers Washington Bureau and the Center for Responsive Politics found a revolving door between Capitol Hill staffers and lobbying jobs for companies with a stake in health care legislation.

At least 166 former aides from the nine congressional leadership offices and five committees involved in shaping health overhaul legislation -- along with at least 13 former lawmakers -- registered to represent at least 338 health care clients since the beginning of last year, according to the analysis.

Their health care clients spent $635 million on lobbying over the past two years, the study shows.

The total of insider Lobbyists jumps to 278 when non-health-care firms that reported lobbying on health issues are added in, the analysis found.

Part of the lobbying pressure on current members of Congress and staffers comes from the powerful lure of post-congressional job possibilities.

"There's always a worry they may be thinking about their future employment opportunities when dealing with these issues, particularly with health care, because the stakes are so high and the breadth of the issues -- pharmacies, hospitals, doctors," said Emory University political scientist Alan Abramowitz.

Lobbyists' earnings can dwarf congressional salaries, which currently top out at $174,000 annually for lawmakers and $156,000 for aides, though committee staff members can earn slightly more.

In the health care showdown, insider lobbying influence has magnified the clout of corporate interests and helped steer the debate away from a public insurance option, despite many polls indicating majority support from Americans, according to Rutgers University political scientist Ross Baker.

"It imposes a kind of conservative bias on the discussion," said Baker, himself a former Senate staffer.

The lineup of insiders working for clients with health care interests includes at least 14 former aides to House Majority Leader Steny Hoyer and at least 13 former aides to Montana Democratic Sen. Max Baucus, the chairman of the Finance Committee and a key overseer of the health care overhaul.

Nexon, who is now senior executive vice president of the Advanced Medical Technology Association, is among at least a half-dozen former Kennedy aides lobbying on health care.

Nexon acknowledged the value of congressional connections, "but in the end, it's not who I know, it's what I know."

It makes sense to hire former staffers for the health care showdown because they tend to be "more generalists, dealing with a broad range of issues," something that is in demand for legislation that sprawls across at least a half-dozen federal agencies and encompasses issues ranging from tax policy to hospital reimbursement rates, according to Nexon. But specific issues also get specialized help. Earlier this year, the Christian Science Church hired a former Kennedy staffer, Carolyn Osolinik, and three of her colleagues at the Mayer Brown law firm, all veterans of Capitol Hill. The firm has been paid at least $110,000 so far to push a provision requiring insurers to consider covering Christian Science prayer treatments.

Phil Davis, a senior official of the church, said the church wanted access to decision makers. "The noise level goes sky high. It's hard to get in to talk to people," he said.

The largest insider lobbying cadre belongs to the Pharmaceutical Research and Manufacturers of America, or PhRMA, which employs at least 26 former congressional members and staffers, according to Medill/CRP research.

Two other drug interests, biotech firm Amgen Inc. and the Biotechnology Industry Organization trade group, with at least 24 and 16 insiders respectively, ranked second and fourth among reported hiring over the past two years of lawmakers' former staffers and members of committees considered in the analysis.

"The numbers shouldn't surprise anyone," said Ken Johnson, a PhRMA senior vice president. "Former staffers have a unique understanding of how the legislative process works. And when you are trying to advocate on behalf of smart public policies, you want smart people on your team."

But Bob Edgar, president of Common Cause, a nonpartisan, nonprofit watchdog group, had a harsher assessment, blaming "a toxic cocktail of insiders and money" for short-circuiting a government-run plan that would have competed with private insurers.

"We'll get a bill. And the president will sign it. But it'll be less than the country deserves," said Edgar, a former six-term member of the House.

Health care lobbyists increase their effectiveness by strategically targeting their campaign contributions or the donations of the interests they represent, Edgar said.

Health industry contributions to congressional candidates have more than doubled so far this decade, rising to $127 million in the 2008 election cycle from $56 million in the 2000 election, with disproportionate sums going to the party in power and to members of committees that oversee health care, according to the Center for Responsive Politics.

But lobbyist and former Kennedy staffer Andrew Rosenberg said political conditions, not big money or the predispositions of lobbyists sidelined a public option.

"You could see this coming from a long way off. The Democratic Party is now the big tent party. They have to get to 60 votes. That is the reality," Rosenberg said. "It was going to have to be something that appeals to moderates" opposed to expanding government-run health insurance.






How Lobbyists Pushed Senate Health Care Bill


At least 166 former congressional staffers now working as health-industry lobbyists got their old bosses to give their new bosses big breaks in the pending health-care reform legislation, according to a new report.

For example, David Nexon, a former aide to the late Sen. Ted Kennedy (D-MA), amassed 14 lobbyists with similar résumés to attack a tax in the bill aimed at one of his clients, a medical-device trade association.

They succeeded in cutting the $40 billion tax in half in the current legislation, according to a report by Northwestern University’s Medill News Service, the Center for Responsive Politics, and the Tribune Newspapers' Washington Bureau.

In addition to the former aides, at least 13 former lawmakers are registered to represent a total of 338 health-care clients since the beginning of last year. Since then, those clients spent $635 million lobbying.




View Larger Map


Sources: Chicago Tribune, The Daily Beast, MSNBC, TPM, Huffington Post, Youtube, Google Maps

Friday, December 18, 2009

Dylan Ratigan Blasts Rep. Debbie Wasserman Over Weak Health Care Bill























Morning Meeting Show Host Dylan Ratigan invited Democratic Rep. Debbie Wasserman Schultz to discuss the topic however they both end up in a heated debate, "You can be your own guest" she eventually told Ratigan.


Visit msnbc.com for breaking news, world news, and news about the economy





View Larger Map


Sources: MSNBC, TPM, Dylan Ratigan's Morning Meeting, The Daily Beast, Google Maps